Giles, Ian http://orcid.org/0000-0001-8913-3894
Yee, Chee-Seng http://orcid.org/0000-0003-1715-4869
Gordon, Caroline http://orcid.org/0000-0002-1244-6443
Article History
Accepted: 14 May 2019
First Online: 11 June 2019
Competing interests
: I.G. declares that he has received honoraria and travel grants from UCB and Lupus Academy to speak at educational meetings on topics related to pregnancy in rheumatic disease. C.S.Y. declares that he has consulted for Bristol Myers Squibb, Immupharma and EMD Serono. C.G. declares that she has consulted for and received honoraria from Bristol-Myers Squibb, GlaxoSmithKline, EMD Serono and UCB in relation to lupus clinical trial design and analysis, and has been a member of the speakers’ bureau for GlaxoSmithKline and UCB. C.G. also declares that she has participated in clinical trials sponsored by UCB and funded by Arthritis Research UK with drugs supplied by GlaxoSmithKline.